IPO

Jupiter Life Line Hospitals Limited IPO

Mainboard

Hospital

Listed On: Sep 18, 2023 at ₹ 973.0(NSE)

₹ 14700 /20 Shares

Check Allotment

06 Sep, 2023

Open Date

08 Sep, 2023

Close Date

13 Sep, 2023

Allotment Date

18 Sep, 2023

Listing Date
Price Summary

Last Closing

1,409.00 (91.7%)

52 Week High

1,770.00

52 Week Low

1,266.00

Last Update

19-Dec-2025 3:30 PM
Jupiter Life Line Hospitals Limited IPO Issue Details
  • Issue Price ₹695-735 per equity share
  • Face Value ₹10 Per Equity Share
  • Issue Price Total ₹869.08 Cr :
    #Fresh Issue : 7,374,163 shares(aggregating up to ₹542.00 Cr) +
    #OFS : 4,450,000 shares of ₹10(aggregating up to ₹327.08 Cr)
  • Listing at BSE, NSE
  • List Price 973.0(NSE)
  • Listing Date 2023-09-18
  • Lead Manager ICICI Securities Limited
    Nuvama Wealth Management Limited
    Jm Financial Limited
  • Registrar Kfin Technologies Limited
Jupiter Life Line Hospitals Limited IPO Details
  • Retail Portion 35% (Number of Retail Applications: 2,06,923 Approx),
    (Number of S-HNI Applications : 2,111 Approx),
    (Number of B-HNI Applications : 4,223 Approx)
Jupiter Life Line Hospitals Limited IPO Documents
DRHP
RHP
ANCHOR
Jupiter Life Line Hospitals Limited IPO Details


The IPO of Jupiter Life Line Hospitals Limited is priced at ₹695-735 per equity share, which has a face value of ₹10 Per Equity Share each, IPO bidding starts from Sep 6, 2023 and ends on Sep 8, 2023. The allotment for Jupiter Life Line Hospitals Limited IPO will be finalized on Sep 13, 2023. Jupiter Life Line Hospitals Limited IPO will be listed on BSE, NSE, with a tentative listing date fixed as Sep 18, 2023. The company shall list its equity shares on the BSE, NSE. Kfin Technologies Limited is the registrar of the issue.

The book-running lead manager for the IPO is/are ICICI Securities Limited, Nuvama Wealth Management Limited, Jm Financial Limited.


The Jupiter Life Line Hospitals Limited IPO sets its price band at 695-735 for each share. A single application for Jupiter Life Line Hospitals Limited IPO must contain at least 20 shares.

Read More
Jupiter Life Line Hospitals Limited IPO Subscription Analysis And Details
Retail
7.71x
QIB
187.32x
NII
34.75x
bNII
39.24x
sNII
25.77x
Total
63.71x
As on QIB NII
bNII   sNII 		Retail Total
Shares Offered / Reserved 2,443,743 1,773,625
1,182,416    591,209 		4,138,458 8,355,826
Day 1 06-09-23 05:00 PM
0.01 x 1.43
1.23 x   1.83 x 		1.10 x 0.87 x
Day 2 07-09-23 05:00 PM
1.03 x 6.63
6.65 x   6.59 x 		3.07 x 3.27 x
Day 3 08-09-23 05:00 PM
187.32 x 34.75
39.24 x   25.77 x 		7.71 x 63.71 x
Total No of Applications
14,55,252
Subscription on the basis of Applications
7.03
Jupiter Life Line Hospitals Limited Valuations
Earnings Per Share (EPS) ₹13.95/-
P/E Ratio 52.68
RoNW 20.03%
Net Asset Value (NAV) - As on 31.03.23 ₹64.39
Jupiter Life Line Hospitals Limited Company Financials
In Crs.
In Cr.
31-Mar-23 31-Mar-22 31-Mar-21
Assets 985.53 908.70 788.91
Revenue 902.96 737.14 490.27
Profit After Tax 72.91 51.13 -2.30
About Jupiter Life Line Hospitals Limited Company

Jupiter Life Line Hospitals Limited is a multi-specialty tertiary and quaternary healthcare provider in the Mumbai Metropolitan Area (MMR) and western region of India.

Jupiter Life Line Hospitals has been operating as a corporate quaternary care healthcare service provider in the western regions of India and currently operates three hospitals under the Jupiter brand in Thane, Pune, and Indore, with a total operational bed capacity of 1194 beds, and 1,306 doctors including specialists, physicians, and surgeons, as of March 31, 2023. The company is currently developing a multi-specialty hospital in Dombivli, Maharashtra, which is designed to accommodate over 500 beds and has commenced construction in April 2023.

According to the CRISIL Report, the company's Thane and Indore hospitals are amongst the few hospitals in the western region of India to provide neuro-rehabilitation services through a dedicated robotic and computer-assisted neuro-rehabilitation center. Additionally, it operates one of the few multi-organ transplant centers in Thane. All the hospitals in Thane, Pune, and Indore have been certified by the National Accreditation Board for Hospitals & Healthcare Providers (NABH) and have been accredited in the field of medical testing by the National Accreditation Board for Testing and Calibration Laboratories (NABL).

Read More
Jupiter Life Line Hospitals Limited - Promoter(s)

Dr. Ajay Thakker

Dr. Ankit Thakker

Western Medical Solutions LLP

Pre Issue Share Holding : 49.79%

Post Issue Share Holding : 40.91%

Jupiter Life Line Hospitals Limited IPO - Issue Objectives
1

Repayment/pre-payment, in full or part, of borrowings availed from banks by the company and Material Subsidiary

2

General corporate purposes.

Jupiter Life Line Hospitals Limited IPO - Anchor Investors

Jupiter Life Line Hospitals mops up Rs 260.72 crore via anchor book ahead of IPO.
As many as 39 investors made an investment in the company via anchor book including marquee names like Government of Singapore, Abu Dhabi Investment Authority, Fidelity Funds, Goldman Sachs, Nomura Funds, HSBC Global, Florida Retirement System, and Natixis International Funds.
Domestic investors including SBI Mutual Fund, ICICI Prudential, Nippon Life, HDFC Mutual Fund, Axis Mutual Fund, Aditya Birla Sun Life Trustee, UTI Mutual Fund, Motilal Oswal MF, HDFC Life Insurance, and SBI Life Insurance Company also participated in the anchor book.

Jupiter Life Line Hospitals Limited IPO - Peers Comparison
P/B Ratio P/E Ratio RoNW Revenue(in Cr.)
Jupiter Life Line 11.41 66.10 20.03% 902
Apollo Hospitals 11.2 104 13.7% 17,235
Fortis Healthcare 3.35 47.0 7.77% 6,467
Narayana Hrudalaya 9.86 30.6 33.1% 4,725
Max Healthcare 7.59 47.8 16.1% 4,778
Krishna Institute 9.27 45.9 21.3% 2,308
Global Health 7.79 51.1 16.2% 2,850